Montag & Associates’s Qiagen QGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding QGEN
Montag & Associates's QGEN Position: Q2 2026 in Review
Montag & Associates sold out of Qiagen (QGEN) in Q2 2026, closing a stake of 12 shares — an estimated $489 sold.
Montag & Associates first reported a position in QGEN in Q1 2024 and held it in 9 quarters. The position peaked at $1.3K in Q2 2025. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.
- Montag & Associates reported no remaining Qiagen position as of Q2 2026 after selling out during the quarter.
- Montag & Associates sold 12 Qiagen shares in Q2 2026, an estimated $489.
- Montag & Associates first reported a position in Qiagen in Q1 2024 and held it in 9 quarters.
- Montag & Associates's Qiagen position peaked at $1.3K in Q2 2025.
- 336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.
Based on Montag & Associates's 13F filing for Q2 2026, filed 5 Aug 2026.